IL117640A - Pharmaceutical compositions for treating immunoinflammatory diseases - Google Patents

Pharmaceutical compositions for treating immunoinflammatory diseases

Info

Publication number
IL117640A
IL117640A IL11764092A IL11764092A IL117640A IL 117640 A IL117640 A IL 117640A IL 11764092 A IL11764092 A IL 11764092A IL 11764092 A IL11764092 A IL 11764092A IL 117640 A IL117640 A IL 117640A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
medicament
treating immunoinflammatory
immunoinflammatory diseases
pref
Prior art date
Application number
IL11764092A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL117640A publication Critical patent/IL117640A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL11764092A 1991-09-17 1992-09-16 Pharmaceutical compositions for treating immunoinflammatory diseases IL117640A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76112091A 1991-09-17 1991-09-17
IL10318992A IL103189A (en) 1991-09-17 1992-09-16 Pharmaceuticals for the treatment of immuno-inflammatory diseases containing an amount of effective rapamycin against immune inflammation

Publications (1)

Publication Number Publication Date
IL117640A true IL117640A (en) 1999-08-17

Family

ID=25061205

Family Applications (3)

Application Number Title Priority Date Filing Date
IL11764092A IL117640A (en) 1991-09-17 1992-09-16 Pharmaceutical compositions for treating immunoinflammatory diseases
IL10318992A IL103189A (en) 1991-09-17 1992-09-16 Pharmaceuticals for the treatment of immuno-inflammatory diseases containing an amount of effective rapamycin against immune inflammation
IL11764096A IL117640A0 (en) 1991-09-17 1996-03-25 Pharmaceutical compositions for treating immunoinflammatory diseases

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL10318992A IL103189A (en) 1991-09-17 1992-09-16 Pharmaceuticals for the treatment of immuno-inflammatory diseases containing an amount of effective rapamycin against immune inflammation
IL11764096A IL117640A0 (en) 1991-09-17 1996-03-25 Pharmaceutical compositions for treating immunoinflammatory diseases

Country Status (23)

Country Link
US (1) US5286730A (cs)
EP (1) EP0533433B1 (cs)
JP (1) JP2810599B2 (cs)
KR (1) KR100299394B1 (cs)
AT (1) ATE151289T1 (cs)
AU (1) AU659868B2 (cs)
CA (1) CA2078379C (cs)
CZ (1) CZ281900B6 (cs)
DE (1) DE69218864T2 (cs)
DK (1) DK0533433T3 (cs)
ES (1) ES2100297T3 (cs)
GR (1) GR3023680T3 (cs)
HK (1) HK108697A (cs)
HU (1) HU211112B (cs)
IL (3) IL117640A (cs)
MX (1) MX9205202A (cs)
NZ (2) NZ328124A (cs)
PH (1) PH30270A (cs)
SG (1) SG43126A1 (cs)
SK (1) SK279521B6 (cs)
TW (1) TW212759B (cs)
UA (1) UA27742C2 (cs)
ZA (1) ZA927010B (cs)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286731A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory bowel disease
JP2741285B2 (ja) * 1992-05-22 1998-04-15 千寿製薬株式会社 緑内障治療剤
US5480988A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5489680A (en) * 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
US5434260A (en) * 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
US5480989A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
DE4329503A1 (de) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
WO1995014023A1 (en) * 1993-11-19 1995-05-26 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5389639A (en) * 1993-12-29 1995-02-14 American Home Products Company Amino alkanoic esters of rapamycin
US5525610A (en) * 1994-03-31 1996-06-11 American Home Products Corporation 42-Epi-rapamycin and pharmaceutical compositions thereof
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5463048A (en) * 1994-06-14 1995-10-31 American Home Products Corporation Rapamycin amidino carbamates
US5849730A (en) * 1994-08-31 1998-12-15 Pfizer Inc. Process for preparing demethylrapamycins
US5561138A (en) * 1994-12-13 1996-10-01 American Home Products Corporation Method of treating anemia
US5496832A (en) * 1995-03-09 1996-03-05 American Home Products Corporation Method of treating cardiac inflammatory disease
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
WO1997031020A1 (en) * 1996-02-22 1997-08-28 The General Hospital Corporation METHODS AND COMPOSITIONS FOR ENHANCING CELLULAR RESPONSE TO TGF-β LIGANDS
ATE340586T1 (de) * 1996-07-30 2006-10-15 Novartis Pharma Gmbh Pharmazeutische zusammensetzungen zur behandlung der transplantatabstossung sowie der autoimmun- oder entzündlichen zustände
CA2270373A1 (en) * 1996-10-31 1998-05-07 American Home Products Corporation Synergistic composition comprising rapamycin and calcitriol
DE19844397A1 (de) * 1998-09-28 2000-03-30 Hilti Ag Abrasive Schneidkörper enthaltend Diamantpartikel und Verfahren zur Herstellung der Schneidkörper
US6670355B2 (en) * 2000-06-16 2003-12-30 Wyeth Method of treating cardiovascular disease
ATE411321T1 (de) 2000-09-19 2008-10-15 Wyeth Corp Wasserlösliche rapamycin-ester
US6399625B1 (en) 2000-09-27 2002-06-04 Wyeth 1-oxorapamycins
US6399626B1 (en) 2000-10-02 2002-06-04 Wyeth Hydroxyesters of 7-desmethylrapamycin
US6440991B1 (en) 2000-10-02 2002-08-27 Wyeth Ethers of 7-desmethlrapamycin
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
TWI286074B (en) 2000-11-15 2007-09-01 Wyeth Corp Pharmaceutical composition containing CCI-779 as an antineoplastic agent
KR20020050135A (ko) * 2000-12-20 2002-06-26 조명재 피부 주름 예방 및 완화를 목적으로 하는 피부 외용 조성물
TWI296196B (en) * 2001-04-06 2008-05-01 Wyeth Corp Antineoplastic combinations
TWI233359B (en) * 2001-04-06 2005-06-01 Wyeth Corp Pharmaceutical composition for treating neoplasm
ZA200603888B (en) * 2001-06-01 2007-05-30 Wyeth Corp Antineoplastic combinations
UA77200C2 (en) 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
CA2455311A1 (en) 2001-08-22 2003-03-06 Wyeth Rapamycin dialdehydes
WO2003018573A1 (en) 2001-08-22 2003-03-06 Wyeth Rapamycin 29-enols
US6641611B2 (en) * 2001-11-26 2003-11-04 Swaminathan Jayaraman Therapeutic coating for an intravascular implant
ES2485841T3 (es) 2002-02-01 2014-08-14 Ariad Pharmaceuticals, Inc Compuestos que contienen fósforo y usos de los mismos
RU2344821C2 (ru) 2002-07-30 2009-01-27 Уайт Парентеральные композиции, содержащие гидроксиэфиры рапамицина
EP1389480A1 (en) * 2002-08-14 2004-02-18 Mondobiotech Interferon SA Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation
CN100415233C (zh) * 2002-09-17 2008-09-03 惠氏公司 口服制剂
AR042938A1 (es) * 2003-02-06 2005-07-06 Wyeth Corp Uso del cci-779 en el tratamiento de la fibrosis hepatica
UA83484C2 (uk) * 2003-03-05 2008-07-25 Уайт Спосіб лікування раку грудей комбінацією похідного рапаміцину і інгібітора ароматази - летрозолу, фармацевтична композиція
EP1615640B1 (en) * 2003-04-22 2007-01-24 Wyeth Antineoplastic combinations
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
ZA200604250B (en) * 2003-11-13 2007-11-28 Combinatorx Inc Methods and reagents for the treatment of inflammatory disorders
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US20070185150A1 (en) 2005-11-14 2007-08-09 Bedrosian Camille L Therapeutic methods
RU2010104916A (ru) * 2006-08-16 2011-08-20 Михаил В. Благосклонный (US) Способ профилактики и лечения возрастных заболеваний
RU2316005C1 (ru) * 2006-09-07 2008-01-27 Государственное учреждение Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского (МОНИКИ им. М.Ф. Владимирского) Способ оценки эффективности лечения пузырчатки
JP6049160B2 (ja) 2006-09-13 2016-12-27 エリクシアー メディカル コーポレイション 大環状ラクトン化合物およびその使用方法
ZA200902909B (en) * 2006-11-07 2010-07-28 Alcon Res Ltd Method of treating asthma, allergic rhinitis, and skin disorders
WO2008063563A2 (en) * 2006-11-16 2008-05-29 Transderm, Inc. Methods of treating keratin hyperproliferation disorders using mtor inhibitors
US20100086579A1 (en) * 2008-10-03 2010-04-08 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
BRPI1010655A2 (pt) 2009-04-10 2019-09-03 Qi Haiyan novos agentes antienvelhecimento e métodos para identificá-los
AU2014209141B2 (en) 2013-01-24 2018-05-10 Palvella Therapeutics, Inc. Compositions for transdermal delivery of mTOR inhibitors
EP3057601A4 (en) * 2013-10-14 2017-06-21 Izun Pharmaceuticals Corp. Methods for treatment of m-tor inhibitor-associated stomatitis
HUP1400075A2 (hu) 2014-02-14 2015-08-28 Druggability Technologies Ip Holdco Jersey Ltd Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói
WO2016094732A1 (en) * 2014-12-10 2016-06-16 Transderm, Inc. METHODS OF TREATING PAIN AND/OR ITCH WITH SMALL MOLECULE INHIBITORS TARGETING AN mTOR PATHWAY
CA3037469C (en) 2015-09-24 2024-04-16 Drexel University Treatment of dermal disorders comprising a mtorc1 inhibitor
CN110520097B (zh) 2017-01-06 2023-10-27 帕尔维拉治疗股份有限公司 Mtor抑制剂的无水组合物及其使用方法
US10456383B2 (en) * 2017-06-01 2019-10-29 The Board Of Trustees Of The Leland Stanford Junior University Targeted approach in the management of Epidermolysis bullosa
EP3817743A4 (en) 2018-07-02 2022-07-06 Palvella Therapeutics, Inc. ANHYDROUS COMPOSITIONS OF MTOR INHIBITORS AND METHODS OF USE
JP2022511270A (ja) * 2018-08-30 2022-01-31 ケミストリーアールエックス． シロリムス含有組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US4023264A (en) * 1976-06-21 1977-05-17 Littelfuse, Inc. Method of making miniature plug-in fuses of different fuse ratings
CH677448A5 (cs) * 1987-11-09 1991-05-31 Sandoz Ag
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5023263A (en) * 1990-08-09 1991-06-11 American Home Products Corporation 42-oxorapamycin
JP2675194B2 (ja) * 1990-08-10 1997-11-12 スミスクライン・ビーチャム・コーポレイション 免疫抑制組成物
US5023262A (en) * 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives
US5078999A (en) * 1991-02-22 1992-01-07 American Home Products Corporation Method of treating systemic lupus erythematosus
US5080899A (en) * 1991-02-22 1992-01-14 American Home Products Corporation Method of treating pulmonary inflammation

Also Published As

Publication number Publication date
ZA927010B (en) 1994-03-14
CA2078379C (en) 2003-07-29
NZ328124A (en) 2000-01-28
DK0533433T3 (da) 1997-05-12
IL117640A0 (en) 1996-07-23
MX9205202A (es) 1993-03-01
HU211112B (en) 1995-10-30
US5286730A (en) 1994-02-15
AU2450792A (en) 1993-03-18
DE69218864T2 (de) 1997-07-17
HU9202955D0 (en) 1992-12-28
PH30270A (en) 1997-02-20
SG43126A1 (en) 1997-10-17
HK108697A (en) 1997-08-22
KR100299394B1 (ko) 2001-10-22
JPH05194529A (ja) 1993-08-03
CZ278592A3 (en) 1993-04-14
UA27742C2 (uk) 2000-10-16
IL103189A0 (en) 1993-02-21
ATE151289T1 (de) 1997-04-15
GR3023680T3 (en) 1997-09-30
SK279521B6 (sk) 1998-12-02
DE69218864D1 (de) 1997-05-15
HUT64846A (en) 1994-03-28
JP2810599B2 (ja) 1998-10-15
TW212759B (cs) 1993-09-11
EP0533433A1 (en) 1993-03-24
AU659868B2 (en) 1995-06-01
ES2100297T3 (es) 1997-06-16
CZ281900B6 (cs) 1997-03-12
EP0533433B1 (en) 1997-04-09
NZ244340A (en) 1999-06-29
IL103189A (en) 1996-08-04
CA2078379A1 (en) 1993-03-18
SK278592A3 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
IL103189A0 (en) Pharmaceutical compositions for treating immunoinflammatory diseases
IE893840L (en) Use of acetyl d-carnitines for treating glaucoma
EP0345302A4 (en) LIPOSOMIC VESICLES FOR THE INTRAPERITONEAL ADMINISTRATION OF THERAPEUTIC AGENTS.
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
ZA926241B (en) Dosage form for delivering drug in short-time period
GR3034186T3 (en) 3,4-diarylchromans for treatment of dermatitis
WO1993007866A3 (en) Compositions and methods for therapy and prevention of cancer, aids, and anemia
LV11728A (lv) Farmaceitiska kompozicija
PL342099A1 (en) Therapeutic agents
LT97135A (en) Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction
NZ514558A (en) Viral treatment
CA2190837A1 (en) Transdermal delivery of anti-epileptic drugs
JPS6483020A (en) Medicinal composition for preventing or treating aids
NO990450L (no) Behandling av sinnslidelser
CZ223199A3 (cs) Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí
CA2077693A1 (en) Use of ketorolac for treatment of periodontal disease
ZA96260B (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts
EP1264601A3 (en) Treatment of a coronary condition by delivery of therapeutics to the pericardial space
AU4250697A (en) Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
IL128494A0 (en) Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
AU3406489A (en) Use of and agent for reducing side effects of tnf
AU4391196A (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
GB9218422D0 (en) Device for administering single doses of medicament
CA2237335A1 (en) The use of cholinesterase inhibitors in the treatment of xerostomia

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HCA Change of name of proprietor(s) after amalgamation
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees